Efficacy and Safety of a Subcutaneous Tanezumab Titration Dosing Regimen in Subjects With Moderate to Severe Osteoarthritis of the Hip or Knee

A Phase 3 Randomized, Double-Blind, Placebo Multicenter Study of the Analgesic Efficacy and Safety of A
Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

Category & Conditions:
Immune System Diseases and Conditions
Medicine:
tanezumab
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
A4091056
Open Plain Language Summary Result:Click here